3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Breast
1
Conditions
Uveal Melanoma
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma
1
Leukemia
1
Hip Fractures
1
Fractures, Spontaneous
1
Dysplastic Nevus Syndrome
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
COVID-19
1
Breast Neoplasms
1
Ataxia Telangiectasia
1
Interventions
Cyclophosphamide
26
Rituximab
22
Biopsy
17
Specimen Handling
16
Prednisone
14
Magnetic Resonance Spectroscopy
14
Doxorubicin
14
fludarabine
12
Vincristine
12
fludarabine phosphate
9
Etoposide
7
Bendamustine Hydrochloride
7
Tacrolimus
6
Nuclear Medicine Department, Hospital
6
Melphalan
6
trametinib
5
acalabrutinib
5
X-Rays
5
Whole-Body Irradiation
5
Radiotherapy
5
Mycophenolic Acid
5
Crizotinib
5
pembrolizumab
4
copanlisib
4
Prednisolone
4
Mesna
4
Lenalidomide
4
Dexamethasone
4
Cytarabine
4
Busulfan
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Lymphoma
×
Data Collection
×
Clear all
NCT04541212
2025-06-15
CarChem
Montreal Heart Institute
Active not recruiting
169 enrolled